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Abstract
Introduction: Drug-induced esophageal ulcers most commonly cause heartburn, midsternal pain and dysphagia.
In our clinic azithromycin is a relative widely used antibiotic for respiratory tract infections and otitis media because
of its activity against Haemophilus influenzae and atypical pathogens, and its ease of administration. After a
thorough search in Pubmed the present case is the first one to report azithromycin-induced esophageal ulcer and
associated symptoms in the literature.
Case presentation: A 61-year-old Caucasian man was admitted to our endoscopy unit for the investigation of
odynophagia and retrosternal pain of new onset. His past medical history was unremarkable but had used
azithromycin 500 mg/d for three days in the previous week. An upper endoscopy revealed an extensive
serpiginous midesophageal ulcer in the presence of a normal squamocolumnar junction and biopsies from the
edges and center of the lesion disclosed no neoplasia or infectious causes but a dense acute inflammatory
infiltrate. The patient was put on a liquid diet, sucralfate proton pump inhibitor treatment and was symptom-free
within two weeks. After four weeks on therapy a repeated upper endoscopic control examination demonstrated
normal findings.
Conclusion: To our knowledge this is the first such a case of azithromycin -induced esophageal ulceration. We
think that a little time taken by the physician to warn the patients for taking every oral drug with sufficient
amount of water might prevent this kind of complications.
Introduction
It is well established that various drugs can cause eso-
phageal mucosal injury, tetracycline, doxycycline, quini-
dine, potassium chloride a n de m e p r o n i u mb r o m i d e
accounting for 90% of reported cases [1]. Severity of
injury ranges from mild inflammatory changes to severe
ulceration, perforation or stricture formation. Common
reason of this complication has been taking medications
just before bedtime, and with a small amount of water
[1,2]. In this report a patient who developed esophageal
ulcers after taking azithromycin (AZM) for upper
respiratory tract infection is presented.
Case presentation
A 61-year-old Caucasian man was admitted to our out-
patient clinic with complaints of heartburn, midsternal
pain, dysphagia and odynophagia for one week. He was
a nonsmoker and denied any use of alcohol, aspirin or
non-steroidal anti inflammatory drugs. His past medical
history was unremarkable but had used AZM 500 mg/d
for three consecutive days after which his complaints
began. His physical examination was normal. He had no
fever, his cardiac and chest auscultation and throat
examinations were normal. An electrocardiography and
chest x-ray revealed no pathological findings. An upper
endoscopy revealed an extensive serpiginous midesopha-
geal ulcer in the presence of a normal squamocolumnar
junction (Figure 1). Biopsies from the edges and center
of the lesion disclosed no neoplasia or infectious causes
but a dense acute inflammatory infiltrate (Figure 2). The
ulceration was thought to be due to AZM intake and
the patient immidiately was put on a liquid diet, and
sucralfate 1 g. qid, and esomeprazole 40 mg. bid treat-
ment and got symptom-free within two weeks. A con-
trol endoscopy demonstrated completely normal
findings after four weeks of therapy. * Correspondence: dryusuferzin@yahoo.com
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Approximately 100 types of drugs have been incrimi-
nated in the etiology of around 1,000 cases of drug-
induced esophageal injury (DIEI). The precise mechan-
ism is not well explained. Multiple factors, including the
increasing age, decreased esophageal peristalsis and
external compression are predisposing to DIEI [3]. But
it is noteworthy that among the reported cases of drug-
induced injury, the proportion of the patients having a
motility disorder such as achalasia and scleroderma or
an anatomical narrowing such as tumor or stricture is
low [3]. Furthermore, drugs that have a large size and
sticky surface are retained longer in the esophagus [4-6].
In addition to these a clinical and experimental study
has shown that doxycycline capsules remain three times
longer in the esophagus than doxycycline tablets [7].
Esophageal damage mostly occurs at the level of phy-
siological narrowings (aortic arch level or above the
lower esophageal sphincter) where the drugs tend to
stick [4]. For this reason it seems to be of utmost
importance to take high risk drugs with sufficient
amount of water.
The most common endoscopic finding is ulcers in
varying size, and depth. In ve r yr a r ec a s e sas t r i c t u r e
formation requireing consequent mechanical dilation
may be observed [3]. Esophageal perforation and hemor-
rhage are rare as well but are life-threatening complica-
tions that require immediate specific and aggressive
treatment.
The main step of treatment should be the withdrawal of
the offending drug. The value of antacids, anti-secretory
drug and proton pump inhibitors remain questionable in
patients without gastroesophageal reflux [5,7]. Apart from
sucralfate, no data from the literature have suggested the
benefit of acid suppression [4]. Severe odynophagia rarely
requires parenteral hydration or, if prolonged, total parent-
eral nutrition. Fortunately, in the majority of patients, DIEI
symptoms resolve within one week [8].
In conclusion, after an thorough literature search in
Pubmed using the keywords AZM and esophagitis, to
our knowledge this is the first such a case of AZM
-induced esophageal ulceration. We think that a little
time taken by the physician to warn the patients for tak-
ing every oral drug with sufficient amount of water
might prevent this kind of complications.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Abbreviations
AZM: azithromycin; DIEI: drug-induced esophageal injury
Author details
1Department of Gastroenterology, Yeditepe University Medical Faculty,
Devlet Yolu Cad 102-104 34752 Kozyatagi, Istanbul, Turkey.
2Department of
Internal Medicine, Yeditepe University Medical Faculty, Devlet Yolu Cad 102-
104 34752 Kozyatagi, Istanbul, Turkey.
3Department of Pathology, Yeditepe
University Medical Faculty, Devlet Yolu Cad 102-104 34752 Kozyatagi,
Istanbul, Turkey.
Authors’ contributions
UA performed the upper endoscopy and endoscopic biopsies. YE, FFY, and
IVS were major contributors in writing the manuscript. IDE performed the
histological examination. CP performed the second look endoscopy.
All authors have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 19 October 2009
Accepted: 3 February 2010 Published: 3 February 2010
Figure 1 A serpiginous, in part circumferential mid-esophageal
ulcer extending to the distal portion in the presence of normal
squamo-columnar junction.
Figure 2 Dense inflammatory infiltrate around the ulcer base
(HE×40).
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